I

Ina Research Inc
TSE:2176

Watchlist Manager
Ina Research Inc
TSE:2176
Watchlist
Price: 899 JPY 0.11% Market Closed
Market Cap: ¥2.7B

Net Margin

10.4%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10.4%
=
Net Income
¥334.8m
/
Revenue
¥3.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10.4%
=
Net Income
¥334.8m
/
Revenue
¥3.2B

Peer Comparison

Country Company Market Cap Net
Margin
JP
Ina Research Inc
TSE:2176
2.7B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.8B USD
Loading...
US
Danaher Corp
NYSE:DHR
152.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
75.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
35.4B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
280B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
36.7B USD
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
30.8B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
US
Waters Corp
NYSE:WAT
22.4B USD
Loading...

Market Distribution

Higher than 77% of companies in Japan
Percentile
77th
Based on 6 917 companies
77th percentile
10.4%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Ina Research Inc
Glance View

Ina Research, Inc. engages in the development of pharmaceutical products. The company is headquartered in Ina-Shi, Nagano-Ken and currently employs 194 full-time employees. The company went IPO on 2008-06-25. The firm operates in two business segments. The Contract Test segment is engaged in the provision of non-clinical test services to confirm the safety and efficacy of developed pharmaceuticals and food materials based on laboratory animals and cells for pharmaceutical development companies, food-related companies, research institutes and others. The Environmental segment is engaged in the design and sale of animal facilities for pharmaceutical companies and universities, deodorant-loaded devices, sterilization equipment, equipment for laboratory animals and others.

Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
10.4%
=
Net Income
¥334.8m
/
Revenue
¥3.2B
How has Net Margin changed over time?

Over the last 3 years, Ina Research Inc’s Net Margin has increased from 2.2% to 10.4%. During this period, it reached a low of 0% on Jun 30, 2020 and a high of 10.4% on May 1, 2022.

Back to Top